BTK Inhibitor Fails to Eliminate Paramagnetic Rim Lesions in MS

(MedPage Today) -- WEST PALM BEACH, Fla. -- Tolebrutinib, an investigational brain-penetrant Bruton's tyrosine kinase (BTK) inhibitor, failed to eliminate paramagnetic rim lesions (PRLs) in people with multiple sclerosis (MS), a small phase IIa...
Source: MedPage Today Neurology - Category: Neurology Source Type: news